Abhinav Bassi's Publications

Hockham C, Kotwal S, Wilcox A et alii
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
Journal articles
2021
Trials
Munch MW, Myatra SN, Vijayaraghavan BKT et alii
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial
Journal articles
2021
JAMA - Journal of the American Medical Association
Munch M, Myatra S, Tirupakuzhi Vijayaraghavan BK et alii
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial
Journal articles
2021
Munch MW, Granholm A, Myatra SN et alii
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan
Journal articles
2021
Acta Anaesthesiologica Scandinavica
Granholm A, Munch MW, Myatra SN et alii
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis
Journal articles
2021
Acta Anaesthesiologica Scandinavica
Ng JKC, Smyth B, Marshall MR et alii
Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis
Journal articles
2021
Nephrology
Granholm A, Munch MW, Myatra SN et alii
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Journal articles
2021
Intensive Care Medicine
John MD O, Arfin S, Paul S et alii
POS-527 CONTINUUM OF CARE AMONG PARTICIPANTS OF DIALYSIS OUTCOMES REGISTRY IN INDIA DURING THE COVID-19 PANDEMIC LOCKDOWN
Journal articles
2021
Kidney International Reports
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D et alii
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: The HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial
Journal articles
2020
Trials
Bassi A, Arfin S, John O et alii
An overview of mobile applications (apps) to support the coronavirus disease 2019 response in India
Journal articles
2020
Indian Journal of Medical Research
BASSI A, John O, Shah D K et alii
SAT-299 Change in Health-Related Quality of Life over 18 Months among Individuals on Maintenance Haemodialysis in India
Journal articles
2020
Kidney International Reports
Bassi A, John MD O, Joshi R et alii
SUN-180 SOCIO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES AT 18 MONTHS OF A COHORT OF ESKD PATIENTS STARTING HEMODIALYSIS IN INDIA
Journal articles
2020
Kidney International Reports
Bassi A, John O, Gallagher M et alii
Methodological challenges to collecting clinical and economic outcome data: Lessons from the pilot dialysis outcomes India study
Journal articles
2019
Nephrology
BASSI A, John O, Joshi R et alii
SAT-039 Socio-Demographic Characteristics, Out of Pocket Expenditure, Quality of Life and Six Months Treatment Outcomes of Haemodialysis Patients in India
Journal articles
2019
Kidney International Reports
Bassi A, John O, Praveen D et alii
Current status and future directions of mhealth interventions for health system strengthening in India: Systematic review
Journal articles
2018
JMIR mHealth and uHealth
Shaikh M, Woodward M, John O et alii
Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India
Journal articles
2018
Kidney International
Gallagher M, Bassi A, John O et alii
Socio-demographics, clinical characteristics, quality of life and geographical access to care of hemodialysis patients in India
Conference Papers
2018
Copenhagen
Kumar Tirupakuzhi Vijavaraghavan B, Jha V, Rajbhandari D et alii
http://dx.doi.org/10.2139/ssrn.3927782
Preprints
Hydroxychloroquine Plus Standard Personal Protective Equipment Versus Standard Personal Protective Equipment Alone for the Prevention of Laboratory Confirmed Covid-19 Infections Among Healthcare Workers: A Multi-Centre Parallel Group Randomized Controlled Trial from India
McGree JM, Hockham C, Kotwal S et alii
http://dx.doi.org/10.1101/2021.08.17.21262196
Preprints
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
Ghosh A, Bhattacharya A, Jha V et alii
Journal articles
'Statistical Analysis Plan for the HydrOxychloroquine Prophylaxis Evaluation (HOPE) trial'
http://dx.doi.org/10.31219/osf.io/uw3ed
Bassi A, Arfin S, John O et alii
Journal articles
'Innovative mobile-health led Participatory Approach to Comprehensive Screening and Treatment of Diabetes (IMPACT Diabetes): Rationale, Design and Baseline Characteristics (Preprint)'
http://dx.doi.org/10.2196/preprints.26921
Bassi A, John O, Praveen D et alii
Journal articles
'Current Status and Future Directions of mHealth Interventions for Health System Strengthening in India: Systematic Review (Preprint)'
http://dx.doi.org/10.2196/preprints.11440

Abhinav Bassi's Publications

Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan

Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis

Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

POS-527 CONTINUUM OF CARE AMONG PARTICIPANTS OF DIALYSIS OUTCOMES REGISTRY IN INDIA DURING THE COVID-19 PANDEMIC LOCKDOWN

An overview of mobile applications (apps) to support the coronavirus disease 2019 response in India

SAT-299 Change in Health-Related Quality of Life over 18 Months among Individuals on Maintenance Haemodialysis in India

SUN-180 SOCIO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES AT 18 MONTHS OF A COHORT OF ESKD PATIENTS STARTING HEMODIALYSIS IN INDIA

Methodological challenges to collecting clinical and economic outcome data: Lessons from the pilot dialysis outcomes India study

SAT-039 Socio-Demographic Characteristics, Out of Pocket Expenditure, Quality of Life and Six Months Treatment Outcomes of Haemodialysis Patients in India

Current status and future directions of mhealth interventions for health system strengthening in India: Systematic review

Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India

Socio-demographics, clinical characteristics, quality of life and geographical access to care of hemodialysis patients in India

http://dx.doi.org/10.2139/ssrn.3927782

http://dx.doi.org/10.1101/2021.08.17.21262196

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country